ShadowBuys

Novo Nordisk A/S (NVO)

Healthcare · Drug Manufacturers - General

14 members of Congress have disclosed 36 trades in Novo Nordisk A/S (NVO) since 2017: 22 buys and 14 sales. The most recent was disclosed on Sep 25, 2026. 2 trades were made by members of a committee that oversees Novo Nordisk A/S's industry.

Trades disclosed
36
Members trading
14
Buys / sells
22 / 14
Reported value
$468K–$1.5M

Keep following the company.

Subscribers get new congressional filings and notable insider purchases for companies they follow. Coverage varies by company.

Follow NVO

What else is happening at NVO

All research →

Company filings and public records connected to this stock, ordered by when they became public or were first observed.

  1. NVOCompany announcement·SEC EDGAR

    NVO: 6-K company filing

    Filed 6-K for an event or period dated 2026-11-05. Read the company report for its disclosures.

    Public: Nov 5, 2026, 1:06 PM ESTEvent / period: Nov 5, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. NVOCompany announcement·SEC EDGAR

    NVO: 6-K company filing

    Filed 6-K for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 4, 2026, 7:47 AM ESTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. NVOCompany announcement·SEC EDGAR

    NVO: 6-K company filing

    Filed 6-K for an event or period dated 2026-11-03. Read the company report for its disclosures.

    Public: Nov 3, 2026, 10:54 AM ESTEvent / period: Nov 3, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  4. NVOCompany announcement·SEC EDGAR

    NVO: 6-K company filing

    Filed 6-K for an event or period dated 2026-10-26. Read the company report for its disclosures.

    Public: Oct 26, 2026, 12:33 PM EDTEvent / period: Oct 26, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  5. NVOCompany announcement·SEC EDGAR

    NVO: 6-K company filing

    Filed 6-K for an event or period dated 2026-10-19. Read the company report for its disclosures.

    Public: Oct 19, 2026, 8:31 AM EDTEvent / period: Oct 19, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

Committee overlaps

Trades by members of a committee that oversees Novo Nordisk A/S's industry. An overlap is a fact about the trade, not evidence of wrongdoing.

Who traded NVO

All trades

From periodic transaction reports filed under the STOCK Act. Amounts are the ranges members report, and trades can be disclosed up to 45 days after they happen. Nothing here is investment advice.